| Item Type | Name |
|
Academic Article
|
Post-splenectomy pancreatic pseudocyst and extensive thrombosis of the portal venous system in a liver transplant recipient.
|
|
Academic Article
|
Hepatic haemangioendothelioma in adults: excellent outcome following liver transplantation.
|
|
Academic Article
|
Liver transplantation for chronic graft-versus-host disease: case report with 10-year follow-up.
|
|
Academic Article
|
Liver transplantation with preservation of the inferior vena cava in case of symptomatic adult polycystic disease.
|
|
Academic Article
|
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence.
|
|
Academic Article
|
Assembly of biliary lipids in native hepatic bile after orthotopic liver transplantation: A biochemical and ultra-structural study in humans.
|
|
Academic Article
|
Cyclosporine A versus tacrolimus monotherapy. Comparison on bile lipids in the first 3 months after liver transplant in humans.
|
|
Academic Article
|
Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension.
|
|
Academic Article
|
Operational tolerance in clinical liver transplantation: emerging developments.
|
|
Academic Article
|
Vascular and rare liver tumors: a good indication for liver transplantation?
|
|
Academic Article
|
Successful treatment of haemothorax following percutaneous liver biopsy using interventional radiology: importance of arterial anatomical variations.
|
|
Academic Article
|
Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients.
|
|
Academic Article
|
Primary carcinoids of the liver: a review of symptoms, diagnosis and treatments.
|
|
Academic Article
|
Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C.
|
|
Academic Article
|
Liver transplantation for the treatment of nodular regenerative hyperplasia.
|
|
Academic Article
|
Cell and organ bioengineering technology as applied to gastrointestinal diseases.
|
|
Academic Article
|
The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up.
|
|
Academic Article
|
Liver bioengineering: current status and future perspectives.
|
|
Academic Article
|
Successful treatment of recurrent cholangitis after adult liver transplantation with a Tsuchida antireflux valve.
|
|
Academic Article
|
Vaginal bleeding complicating portal hypertension: a particular entity - report of two cases and review of the literature.
|
|
Academic Article
|
Liver transplantation for hereditary hemorrhagic telangiectasia: Report of the European liver transplant registry.
|
|
Academic Article
|
Non-transplant surgical approach to liver-based hereditary haemorrhagic telangiectasia: a first report.
|
|
Academic Article
|
The place of liver transplantation in the treatment of hepatic epitheloid hemangioendothelioma: report of the European liver transplant registry.
|
|
Academic Article
|
The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months.
|
|
Academic Article
|
Tacrolimus monotherapy in liver transplantation: one-year results of a prospective, randomized, double-blind, placebo-controlled study.
|
|
Academic Article
|
Operational tolerance after liver transplantation.
|
|
Academic Article
|
Regenerative medicine as applied to solid organ transplantation: current status and future challenges.
|
|
Academic Article
|
Successful treatment of systemic de novo sarcoidosis with cyclosporine discontinuation and provision of rapamune after liver transplantation.
|
|
Academic Article
|
How regenerative medicine may contribute to the achievement of an immunosuppression-free state.
|
|
Academic Article
|
Regenerative medicine as applied to general surgery.
|
|
Academic Article
|
Regeneration and bioengineering of the gastrointestinal tract: current status and future perspectives.
|
|
Academic Article
|
Hepatic hemangiosarcoma: an absolute contraindication to liver transplantation--the European Liver Transplant Registry experience.
|
|
Concept
|
Liver Diseases
|
|
Concept
|
Liver Cirrhosis
|
|
Concept
|
Liver
|
|
Concept
|
Liver Transplantation
|
|
Concept
|
Liver Function Tests
|
|
Concept
|
Liver Neoplasms
|
|
Concept
|
Liver Regeneration
|
|
Concept
|
Liver Failure
|
|
Academic Article
|
Is minimal, [almost] steroid-free immunosuppression a safe approach in adult liver transplantation? Long-term outcome of a prospective, double blind, placebo-controlled, randomized, investigator-driven study.
|
|
Academic Article
|
Current achievements and future perspectives in whole-organ bioengineering.
|
|
Academic Article
|
The efficacy and safety of mammalian target of rapamycin inhibitors ab initio after liver transplantation without corticosteroids or induction therapy.
|
|
Academic Article
|
Proceedings of the signature series event of the international society for cellular therapy: "Advancements in cellular therapies and regenerative medicine in digestive diseases," London, United Kingdom, May 3, 2017.
|